The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 14, issue 6, 2013

Channeling health economics research initiatives to improve decision-making processes in the EU pp. 847-852

F. Antonanzas and R. Rodríguez-Ibeas

Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease pp. 853-861

Monia Marchetti, Nicola Liberato, Antonio Sabatino and Gino Corazza

The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice pp. 863-873

Ingrid Lekander, Fredrik Borgström, Jörgen Lysholm, Ronald Vollenhoven, Staffan Lindblad, Pierre Geborek and Gisela Kobelt

Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries pp. 875-885

P. Laires, F. Exposto, R. Mesquita, A. Martins, L. Cunha-Miranda and J. Fonseca

The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies pp. 887-899

Jen Kruger and Alan Brennan

Internal validation of models with several interventions pp. 901-909

Afschin Gandjour and Amiram Gafni

Quantifying short run cost-effectiveness during a gradual implementation process pp. 911-918

Gijs Wetering, Willem Woertman, Andre Verbeek, Mireille Broeders and Eddy Adang

Explaining length of stay variation of episodes of care in the Netherlands pp. 919-927

Siok Tan, Leona Hakkaart- van Roijen, B. Ineveld and W. Redekop

Managing for efficiency in health care: the case of Greek public hospitals pp. 929-938

Panagiotis Mitropoulos, Ioannis Mitropoulos and Aris Sissouras

Treatment costs of attention deficit hyperactivity disorder in Germany pp. 939-945

Sebastian Braun, Jan Zeidler, Roland Linder, Susanne Engel, Frank Verheyen and Wolfgang Greiner

Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information pp. 947-957

Leyla Mohseninejad, Talitha Feenstra, Henriëtte Horst, Hèlen Woutersen-Koch and Erik Buskens

The impact of generic reference pricing in Italy, a decade on pp. 959-969

Simone Ghislandi, Patrizio Armeni and Claudio Jommi

Maximal endurable time states and the standard gamble: more preference reversals pp. 971-977

P. Stalmeier and A. Verheijen

How efficient are Greek hospitals? A case study using a double bootstrap DEA approach pp. 979-994

Kostantinos Kounetas and Fotis Papathanassopoulos

Cost-effectiveness analysis, prevention of atopic dermatitis by oral application of bacterial lysate in newborns/small children pp. 995-1002

Peter Kiencke, Kristina Viehmann and Reinhard Rychlik

Long-term health investment when people underestimate their adaptation to old age-related health problems pp. 1003-1013

Octave Jokung and Serge Macé

Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany pp. 1015-1026

Bernhard Ultsch, Ingrid Köster, Thomas Reinhold, Anette Siedler, Gérard Krause, Andrea Icks, Ingrid Schubert and Ole Wichmann

TIPP and Lichtenstein modalities for inguinal hernia repair: a cost minimisation analysis alongside a randomised trial pp. 1027-1034

G. Koning, E. Adang, P. Stalmeier, F. Keus, P. Vriens and C. Laarhoven

Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation pp. 1035-1048

Björn Stollenwerk, Afschin Gandjour, Markus Lüngen and Uwe Siebert

Volume 14, issue 5, 2013

Could co-payments on drugs help to make EU health care systems less open to political influence? pp. 709-713

Livio Garattini and Katelijne Vooren

Analysis of HIV/AIDS DRG in Portugal: a hierarchical finite mixture model pp. 715-723

Sara Dias, Valeska Andreozzi and Rosário Martins

Soft budget constraints in health care: evidence from Italy pp. 725-737

Rosella Levaggi and Francesco Menoncin

Public preferences for establishing nephrology facilities in Greenland: estimating willingness-to-pay using a discrete choice experiment pp. 739-748

Trine Kjær, Mickael Bech, Christian Kronborg and Morten Mørkbak

Utility elicitation study in the UK general public for late-stage chronic lymphocytic leukaemia pp. 749-759

Keith Tolley, Catherine Goad, Yunni Yi, Penny Maroudas, Amin Haiderali and Gwilym Thompson

Examining the determinants of drug launch delay in pre-TRIPS India pp. 761-773

Saradindu Bhaduri and Thomas Brenner

Evaluating the redistributive impact of public health expenditure using an insurance value approach pp. 775-787

Amedeo Spadaro, Lucia Mangiavacchi, Ignacio Moral-Arce, Marta Adiego-Estella and Angela Blanco-Moreno

The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop pp. 789-797

Carla Guerriero, John Cairns, Ian Roberts, Anthony Rodgers, Robyn Whittaker and Caroline Free

Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study pp. 799-808

Sarah Mostardt, Nikola Hanhoff, Juergen Wasem, Armin Goetzenich, Knud Schewe, Eva Wolf, Christoph Mayr, Hans Jaeger, Holger Pfaff, Stephan Dupke and Anja Neumann

Hospital readmission among elderly patients pp. 809-820

Afsaneh Bjorvatn

What determines health: a causal analysis using county level data pp. 821-834

Andrew Rettenmaier and Zijun Wang

Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries pp. 835-846

Christian Eckmann, Matthew Wasserman, Faisal Latif, Graeme Roberts and Axelle Beriot-Mathiot

Volume 14, issue 4, 2013

The present state of health economics: a critique and an agenda for the future pp. 569-571

Peter Zweifel

Welfare standards in hospital mergers pp. 573-586

Katalin Katona and Marcel Canoy

Assessing the impact of national antibiotic campaigns in Europe pp. 587-599

Massimo Filippini, L. Ortiz and Giuliano Masiero

What do physicians dislike about managed care? Evidence from a choice experiment pp. 601-613

Maurus Rischatsch and Peter Zweifel

What accounts for the regional differences in the utilisation of hospitals in Germany? pp. 615-627

Boris Augurzky, Thomas Kopetsch and Hendrik Schmitz

Palliative treatment of colorectal cancer in Germany: cost of care and quality of life pp. 629-638

Martin Emmert, Katharina Pohl-Dernick, Axel Wein, Frank Dörje, Susanne Merkel, Frank Boxberger, Gudrun Männlein, Robert Joost, Hans-Detlev Harich, Roland Thiemann, Christof Lamberti, Markus Neurath, Werner Hohenberger and Oliver Schöffski

Measuring Worksite Health Promotion Programs: an application of Structural Equation Modeling with ordinal data pp. 639-653

Fredrik Ødegaard and Pontus Roos

The economic burden of atherothrombosis in Greece: results from the THESIS study pp. 655-665

Nikos Maniadakis, Georgia Kourlaba, Dennis Cokkinos, Aggeliki Angeli and John Kyriopoulos

Competition in prescription drug markets: the roles of trademarks, advertising, and generic names pp. 667-675

Roger Feldman and Félix Lobo

The effect of stimulants and their combined use with cigarettes on mortality: the case of betel quid pp. 677-695

Shao-Hsun Keng and Sheng-Jang Sheu

The effect of chronic conditions on stated preferences for health pp. 697-702

A. Pickard, Rima Tawk and James Shaw

Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 pp. 703-705

Christopher Sampson, David Whitehurst and Andrew Street

Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A reply to Christopher James Sampson pp. 707-708

Peter Kooreman and Erik Baars

Volume 14, issue 3, 2013

HAS to be NICE? pp. 363-366

Gérard Pouvourville

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement pp. 367-372

Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew Briggs, Josephine Mauskopf and Elizabeth Loder

Redistributional consequences of early childhood intervention pp. 373-381

Tim Lohse, Peter Lutz and Christian Thomann

Problems of priority change in kidney allocation and beyond pp. 383-390

Marlies Ahlert and Hartmut Kliemt

Bargaining and the provision of health services pp. 391-406

Luigi Siciliani and Anderson Stanciole

Terminal patients in Belgian nursing homes: a cost analysis pp. 407-413

Steven Simoens, Betty Kutten, Emmanuel Keirse, Paul Berghe, Claire Beguin, Marianne Desmedt, Myriam Deveugele, Christian Léonard, Dominique Paulus and Johan Menten

Effects of competition on hospital quality: an examination using hospital administrative data pp. 415-429

Alfons Palangkaraya and Jongsay Yong

Welfare-related health inequality: does the choice of measure matter? pp. 431-442

Joachim Frick and Nicolas Ziebarth

Diffusion of innovations in social interaction systems. An agent-based model for the introduction of new drugs in markets pp. 443-455

Julio Pombo-Romero, Luis Varela and Carlos Ricoy

Does the US health care safety net discourage private insurance coverage? pp. 457-469

Xuezheng Qin and Gordon Liu

The impact of time cost of physical exercise on health outcomes by older adults: the DR’s EXTRA Study pp. 471-479

Virpi Kuvaja-Köllner, Hannu Valtonen, Pirjo Komulainen, Maija Hassinen and Rainer Rauramaa

Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland pp. 481-493

Jonas Nilsson, Örjan Åkerborg, Gaëlle Bégo-Le Bagousse, Mårten Rosenquist and Peter Lindgren

Drug expenditure of high-cost patients and their characteristics in Finland pp. 495-502

Leena Saastamoinen and Jouko Verho

Systems GMM estimates of the health care spending and GDP relationship: a note pp. 503-506

Saten Kumar

Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales pp. 507-514

Ruth Brown, Sean Stern, Sujith Dhanasiri and Steve Schey

Inter-regional competition and quality in hospital care pp. 515-526

Hiroshi Aiura

Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries pp. 527-538

Richard Heijink, Xander Koolman and Gert Westert

Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients pp. 539-550

Lene Lunde

How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus pp. 551-568

Thomas Wilke, Antje Groth, Sabrina Mueller, Dallas Reese, Roland Linder, Susanne Ahrens and Frank Verheyen

Volume 14, issue 2, 2013

Resource allocation strategies in Southeastern European health policy pp. 153-159

Mihajlo (Michael) Jakovljevic

Self-control and support for anti-smoking policies among smokers, ex smokers, and never smokers pp. 161-170

Lourdes Badillo Amador and Ángel López Nicolás

The welfare implications of disability for older people in Ireland pp. 171-183

John Cullinan, Brenda Gannon and Eamon O’Shea

Economic evaluation of URMEL-ICE, a school-based overweight prevention programme comprising metabolism, exercise and lifestyle intervention in children pp. 185-195

Dorothea Kesztyüs, Anja Schreiber, Tamara Wirt, Martina Wiedom, Jens Dreyhaupt, Susanne Brandstetter, Benjamin Koch, Olivia Wartha, Rainer Muche, Martin Wabitsch, Reinhold Kilian and Jürgen Steinacker

The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries pp. 197-209

Raymond Oppong, Billingsley Kaambwa, Jacqueline Nuttall, Kerenza Hood, Richard Smith and Joanna Coast

Trends in social class inequalities in the use of health care services within the Spanish National Health System, 1993–2006 pp. 211-219

Laia Palència, Albert Espelt, Maica Rodríguez-Sanz, Katia B. Rocha, M. Isabel Pasarín and Carme Borrell

An analysis of the influence of framework aspects on the study design of health economic modeling evaluations pp. 221-230

Sebastian Gurtner

Mapping utility scores from the Barthel index pp. 231-241

Billingsley Kaambwa, Lucinda Billingham and Stirling Bryan

The influence of social deprivation on length of hospitalisation pp. 243-252

Engin Yilmaz and Denis Raynaud

Determinants of healthcare system’s efficiency in OECD countries pp. 253-265

Sharon Hadad, Yossi Hadad and Tzahit Simon-Tuval

Organisational determinants of production and efficiency in general practice: a population-based study pp. 267-276

Kim Olsen, Dorte Gyrd-Hansen, Torben Sørensen, Troels Kristensen, Peter Vedsted and Andrew Street

Using respondents’ uncertainty scores to mitigate hypothetical bias in community-based health insurance studies pp. 277-285

Hermann Donfouet, Pierre-Alexandre Mahieu and Eric Malin

Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan pp. 287-295

Chee-Ruey Hsieh, Ya-Ming Liu and Chia-Lin Chang

Moving beyond a limited follow-up in cost-effectiveness analyses of behavioral interventions pp. 297-306

Rilana Prenger, Marcel Pieterse, Louise Braakman-Jansen, Job Palen, Lieke Christenhusz and Erwin Seydel

Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients pp. 307-314

Nick Kontodimopoulos, Panagiotis Bozios, John Yfantopoulos and Dimitris Niakas

Rationing and deprivation: disease-modifying therapies for multiple sclerosis in the United Kingdom pp. 315-321

Trudy Owens, Nikos Evangelou and David Whynes

The impact of health insurance mandates on drug innovation: evidence from the United States pp. 323-344

Natalie Chun and Minjung Park

Impact of parallel trade on pharmaceutical firm’s profits: rise or fall? pp. 345-355

Shen Guo, Bin Hu and Hai Zhong

The Grossman model after 40 years: a reply to Peter Zweifel pp. 357-360

Robert Kaestner

The Grossman model after 40 years: response to Robert Kaestner pp. 361-362

Peter Zweifel

Volume 14, issue 1, 2013

Paying doctors for performance pp. 1-4

Gérard Pouvourville

The development of new research methods for the valuation of EQ-5D-5L pp. 1-3

Nancy Devlin and Paul Krabbe

Is health care a luxury or a necessity or both? Evidence from Turkey pp. 5-10

Nilgun Yavuz, Veli Yilanci and Zehra Ozturk

Introducing the composite time trade-off: a test of feasibility and face validity pp. 5-13

Bas Janssen, Mark Oppe, Matthijs Versteegh and Elly Stolk

Measuring health outcomes of adolescents: report from a pilot study pp. 11-19

Yemi Oluboyede, Sandy Tubeuf and Christopher McCabe

The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework pp. 15-24

Nan Luo, Minghui Li, Elly Stolk and Nancy Devlin

Federal state differentials in the efficiency of health production in Germany: an artifact of spatial dependence? pp. 21-39

Stefan Felder and Harald Tauchmann

Lead versus lag-time trade-off variants: does it make any difference? pp. 25-31

Federico Augustovski, Lucila Rey-Ares, Vilma Irazola, Mark Oppe and Nancy Devlin

Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states pp. 33-42

Juan Ramos-Goñi, Oliver Rivero-Arias, María Errea, Elly Stolk, Michael Herdman and Juan Cabasés

The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007 pp. 41-56

Frank Lichtenberg

Time to tweak the TTO: results from a comparison of alternative specifications of the TTO pp. 43-51

Matthijs Versteegh, Arthur Attema, Mark Oppe, Nancy Devlin and Elly Stolk

Time trade-off: one methodology, different methods pp. 53-64

Arthur Attema, Yvette Edelaar-Peeters, Matthijs Versteegh and Elly Stolk

Valuing EQ-5D using Time Trade-Off in France pp. 57-66

Julie Chevalier and Gérard Pouvourville

One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands pp. 65-73

Koonal Shah, Andrew Lloyd, Mark Oppe and Nancy Devlin

What can we learn from international comparisons of costs by DRG? pp. 67-73

M. Pirson, L. Schenker, D. Martins, Duong Dung, J. Chalé and P. Leclercq

Determinants of household direct and indirect costs: an insight for health-seeking behaviour in Burkina Faso pp. 75-84

Tin Su and Steffen Flessa

A cost-effectiveness analysis of the Incredible Years parenting programme in reducing childhood health inequalities pp. 85-94

Donal O’Neill, Sinéad McGilloway, Michael Donnelly, Tracey Bywater and Paul Kelly

Body weight and health-related quality of life in Catalonia, Spain pp. 95-105

Juan Oliva and Ana Gil-Lacruz

Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall pp. 107-115

E. Wetering, E. Stolk, Job van Exel and Werner Brouwer

Key issues in the design of pay for performance programs pp. 117-131

Frank Eijkenaar

Food prices and overweight patterns in Italy pp. 133-151

Luca Pieroni, D. Lanari and Luca Salmasi